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Apoptosis is a physiological programmed cell death pro-
cess whose dysregulation plays an important role in dif-
ferent human infectious diseases. An increasing number
of intracellular pathogens are known to induce target
cell apoptosis, while some other parasites inhibit it. Unlike
necrosis, apoptosis is a silent immunological event oc-
curring without inflammation. Infection-induced target
cell apoptosis may be a successful strategy to eliminate
pathogens and assure host survival. Conversely, apopto-
sis inhibition could represent an adaptive mechanism for
pathogen survival, while it may be beneficial for the host
to initiate an effective immune response.
The worldwide increase in tuberculosis has stimu-
lated more research aimed at defining the interaction be-
tween Mycobacterium tuberculosis and the immune sys-
tem. M. tuberculosis possesses sophisticated strategies
to circumvent its fate within target monocytic cells. Apo-
ptosis of alveolar macrophages and monocytes has been
described as a consequence of M. tuberculosis infection.
Moreover, the observation that mycobacterial lipopro-
teins activate macrophages through Toll-like receptor
(TLR) 2 suggests that innate immune receptors contrib-
ute to defence against M. tuberculosis. There is evidence
that TLR-induced apoptosis modulates inflammation
and immune activation during M. tuberculosis infection.
Finally, the role of apoptotic-infected cells as a source of
microbial antigens for cross-priming of effector T-cells is
also discussed.
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THE RECENT worldwide increase in tuberculosis
(TB) and the urgent need for a new and more effective
vaccine have stimulated research aimed at defining the
interaction between mycobacteria, host cells and the
immune system. Cells of the monocytic lineage, and
especially alveolar macrophages (AMs), are among
the first host cells encountered by inhaled Mycobacte-
rium tuberculosis deep in the lung.1 Initially, resting
phagocytes are poorly equipped to inhibit the growth
of mycobacteria because of the pathogen’s ability to
take advantage of internalisation mechanisms. The
host response ultimately results in the induction of
cell-mediated immunity, which is relatively effective in
containing the infection.2–4 Caseating granuloma is the
hallmark of an adequate immunological response
whose organisation depends on intercellular contacts
and on locally secreted cytokines and chemokines.5,6
Apoptosis is a physiological process of programmed
cell death, involved during development and cell ho-
meostasis. Apoptosis dysregulation plays an impor-
tant role in different human infectious diseases.7 To
date, an increasing number of intracellular pathogens,
including mycobacteria, have been identified to mod-
ulate apoptosis of target cells. Since the characterisation
of morphological, molecular and metabolic features of
apoptosis, many differences have been described in
comparison with necrosis. Necrosis is a passive event
leading to an inflammatory infiltrate involving many
adjoining cells. Unlike necrosis, apoptosis is a silent,
self-limiting process.8,9 The quick removal of dying
cells by neighbouring phagocytes avoids the spillage
of intracellular contents causing inflammation and
tissue destruction and prevents antigen (Ag) presenta-
tion. Figure 1 summarises the main differences between
apoptosis and necrosis. However, more recent find-
ings suggest that apoptosis modulates inflammation
and immune activation, as discussed.
MYCOBACTERIA AND TARGET 
MACROPHAGE/MONOCYTE APOPTOSIS
Cells of the monocytic lineage are the main effectors
against a broad spectrum of intracellular pathogens,
including viruses, fungi, protozoa and mycobacteria.10
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To eliminate highly resistant pathogens, tissue macro-
phages and locally recruited monocytes must be
primed by T-cell derived pro-inflammatory cytokines.11
Activation of phagocytes is a crucial step for the host
defence, but these cells are nevertheless dangerous be-
cause of their production of free radicals, lytic en-
zymes and inflammatory mediators. These molecules
are responsible for extensive local tissue damage and
for many local and systemic symptoms associated with
inflammation. Apoptosis may eliminate no longer nec-
essary activated cells and limit their destructive poten-
tial as inflammation wanes. The influence of myco-
bacteria on target cell apoptosis has received increasing
attention over the last few years. Tissue macrophages
are robust, long-living cells resistant to different apo-
ptotic stimuli with few known mechanisms able to
limit their activation.12,13 M. tuberculosis is a potent
apoptosis promoter of human macrophages.14–17 Tar-
get cell apoptosis is mainly mediated by the expres-
sion of tumour necrosis factor-alpha (TNF-a) . This
effect is enhanced by the participation of cytosolic
phospholipase A2,18 and is antagonised by the man-
nosylated lipoarabinomannan (ManLAM) through the
alteration of Ca11 dependent cell signalling.19 There
is evidence that infection with the virulent M. tuber-
culosis H37Rv and Erdman strains produces a less
significant effect on cell viability than infection with
the attenuated strain H37Ra, or when M. kansasii or
M. bovis bacille Calmette-Guérin (BCG) are used.20,21
This result is mediated by the ability of virulent M.
tuberculosis strains to induce the release by infected
cells of soluble TNF-receptor 2 molecules which bind
TNF-a, leading to its inactivation.22 Figures 2 and 3
show examples of mycobacteria-induced apoptosis of
human macrophages by means of different apoptosis
detection procedures.
Unlike tissue macrophages, peripheral monocytes
spontaneously undergo apoptosis when entering the
inflamed site, unless given permission by inflamma-
tory mediators or growth factors.23,24 There is evidence
that monocytes are less prone to undergoing apoptosis
when infected in vitro with mycobacteria, unless high
mycobacterial doses are used.15 Indeed, low numbers
of M. tuberculosis H37Rv prevent apoptosis of target
human monocytes and promote the release of TNF-a.25
In a similar fashion, M. bovis BCG increases the via-
bility of infected monocytes, priming the secretion of
TNF-a and inhibiting that of interleukin-10 (IL-10).26
GENETIC FACTORS AND MYCOBACTERIA-
RELATED TARGET CELL APOPTOSIS
Growing evidence suggests that susceptibility or resis-
tance to mycobacterial infection and target cell apo-
ptosis is genetically determined. As shown in the animal
model, the genetic background may account for target
cell apoptosis/survival through the production of nitric
oxide (NO) and the expression of pro-inflammatory
and anti-inflammatory cytokines at the site of infec-
tion.27 Resistant M. tuberculosis-infected murine
macrophages (Bcg-r) undergo apoptosis and release
high levels of NO and TNF-a, while M. tuberculosis-
sensitive cells (Bcg-s) are resistant to apoptosis and
produce lower levels of NO and TNF-a and high levels
of IL-10.28,29 Genetic factors may affect human sus-
ceptibility to TB, but no specific genes have yet been
identified. The role of the human homologue of the
NRAMP1 gene, which influences susceptibility to TB
infection in mice, is still unknown.30,31 Bellamy et al.
have suggested NRAMP1 as a strong candidate for
human TB because of the association of some NRAMP1
polymorphisms with the clinical spectrum of the dis-
ease.32 However, the data in the literature remain con-
troversial and further studies are needed.33–35
EFFECT OF TARGET CELL APOPTOSIS 
ON MYCOBACTERIAL SURVIVAL
Mycobacteria display a wide spectrum of survival
strategies to take advantage of internalisation mecha-
nisms and escape the host immune response. Studies
concerning the effect of target cell apoptosis on the vi-
ability of infecting bacilli have provided contrasting
results. Lammas et al. have shown that the addition
of adenosine triphosphate (ATP) to M. tuberculosis-
infected human macrophages culminates with cell sui-
cide and elimination of the bacilli.36 There is evidence
that ATP-mediated activation of purino-receptors
promotes the phagosome-lysosome fusion and induces
significant changes of the intraphagosome pH which
are unsuitable for the growth of mycobacteria.37–40
While H2O2-induced apoptosis of M. avium-intra-
cellulare-infected cells leads to the elimination of myco-
bacteria,41 Fas-mediated cell death is not always cou-
pled with their eradication. Indeed, while Fas ligand
(FasL) induced apoptosis of human macrophages re-
duces the viability of infecting M. tuberculosis,42,43 Fas-
mediated T-cell killing of M. tuberculosis-infected
cells has no effect on mycobacteria.44,45
Reactive nitrogen intermediates (RNI) are effective
Figure 1 Necrosis vs. apoptosis: differences in cell morphology
and cell death outcome.
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Figure 2 Examples of apo-
ptotic cell detection in pulmonary
TB patients. A. Flow cytometric
analysis of propidium iodide
stained apoptotic cells in bron-
choalveolar lavage (BAL) fluid. 
Demonstration of DNA frag-
mentation by TUNEL analysis in
apoptotic alveolar macrophages
(B. nuclear brown staining) and
lung tissue (D. nuclear red
staining) by immunochemistry.
C. Cyto-plasmic protein ag-
gregation in apoptotic cells by
means of tissue transglutami-
nase (tTGase) activity.
Figure 3 Annexin V mem-
brane expression (green fluo-
rescence) and nuclear iodide
propidium (red fluorescence)
staining by confocal laser micros-
copy are shown in uninfected
and M. tuberculosis-infected
human monocyte-derived macro-
phages (MM). Unlike unin-
fected MM (A), early apoptotic
M. tuberculosis-infected cells
are annexin V-positive (B). Ad-
ditional nuclear chromatin con-
densation occurs in late dying
infected MM (C) (magnifica-
tion 363). MOI 5 multiplicity
of infection
378 The International Journal of Tuberculosis and Lung Disease
mediators of host defence mechanisms against micro-
bial agents. It is known that NO plays an essential
antimycobacterial effect in the murine model of TB.
The activation of the inducible NO synthase (iNOS),
which leads to increased production of NO, corre-
lates with host survival.27–29 Findings in human mod-
els are controversial. Enhanced activity of iNOS has
been detected in alveolar macrophages from TB pa-
tients,46 and NO levels are increased in their respira-
tory samples.47 However, the precise mechanism by
which NO antagonises M. tuberculosis is not clear,
but may involve disruption of DNA, proteins, signal-
ling, and/or target cell apoptosis.31,48
Finally, the observation that control of mycobacte-
rial growth may depend on target cell apoptosis comes
from Frattazzi et al., who have shown that apoptotis,
but not necrosis, of M. avium-infected human macro-
phages prevents mycobacteria from spreading and in-
duces their growth inhibition by uninfected bystander
phagocytes.49 The complete inhibition of the intracel-
lular growth of M. avium is achieved due to the syn-
ergic effect of IFN-g and piconilic acid.50
APOPTOSIS AND GRANULOMA: 
IN VIVO FINDINGS
Apoptosis occurs in epithelioid granulomas,51,52 but
few data are currently available. Keane et al. found
more than 50% apoptotic cells in the caseous areas of
lung sections from clinical cases of TB.14 However,
further characterisation of apoptotic cells was not
performed. More recently, the phenotype of dying
cells has been analysed in biopsy specimens from pa-
tients with pulmonary and extra-pulmonary TB.53 In-
terestingly, the majority of CD681 macrophages sur-
rounding the caseous foci expressed the pro-apoptotic
protein Bax and showed typical features of apoptosis,
including Fas expression. Moreover, even adjacent
memory T-cells, expressing both the pro-inflammatory
cytokine, interferon-gamma (IFN-g), and the death
signals, Fas and FasL, are prone to undergoing apo-
ptosis. These data suggest that at least Fas-FasL inter-
action may be involved in vivo in apoptosis of macro-
phages and T-cells in TB granulomas. However, as
these findings cannot be demonstrated in situ, the role
of other pro-apoptotic agents cannot be ruled out.
Finally, the observation that apoptotic cells are
present in productive granulomas, but not in regres-
sive lesions, suggests that apoptosis is an active pro-
cess that modulates local cell-turnover, limiting tissue
damage and spread of infection.53
TARGET CELL APOPTOSIS IN 
HIV-RELATED TUBERCULOSIS
There is wide evidence that M. tuberculosis impacts
on human immunodeficiency virus (HIV) infection
and that HIV promotes mycobacterial diseases. Clin-
ical and experimental data suggest that the interac-
tion of these two pathogens leads to accelerated dis-
ease progression in co-infected patients.54–58 Recent
epidemiological studies have estimated that HIV in-
fection increases the 2–23% lifetime risk of reactiva-
tion of latent TB to 5–10% per year.59,60 HIV infection
is associated with an inadequately increased rate of
T-cell apoptosis due to chronic immune activation. Our
data showing a higher ex vivo rate of apoptosis of
monocytes and AM in M. tuberculosis-HIV co-infected
patients compared to HIV-negative TB patients sup-
port the existence of a synergic interaction between
these two pathogens.15 Moreover, the observation
that apoptosis correlated with disease severity suggests
that death of target cells is an emergency strategy of
the host to eliminate infected reservoirs. Finally, spon-
taneous apoptosis of mononuclear phacocytes and of
Ag-specific CD41 T-cells occurs in patients affected
by TB pleuritis at the site of infection.61
APOPTOSIS, INFLAMMATION AND IMMUNITY: 
THE ROLE OF MYCOBACTERIAL LIPOPROTEINS
More recent data have suggested that apoptosis mod-
ulates inflammation and immune responses. The first
observation that infection-induced target cell apopto-
sis is linked to inflammation comes from Zychlinsky
et al., who found that infection of macrophages by
Shigella flexneri triggers target cell suicide and pro-
motes the cleavage of pro-IL-1b into a mature isoform.
The release of the intracellular store of IL-1b initiates
inflammation through the recruitment of neutrophils
into the infected site.62
The recent finding that pathogen-associated mo-
lecular patterns (PAMPs), including the bacterial cell
wall associated lipoproteins, are ligands of human
Toll-like receptors (TLRs) opens new perspectives for
understanding the host pathogen interaction.63–65 Sig-
nalling through TLRs influences the innate immune
response to infection by upregulation of immunomod-
ulatory molecules and secretion of antibacterial effec-
tors, which may lead to the development of a Th1-
biased response.66,67 It has been shown that the 19-kDa
lipoprotein of M. tuberculosis activates TLR-2,
leading to the induction of target cell apoptosis in as-
sociation with the expression of pro-inflammatory
mediators, as shown in Figure 4.68 Ciaramella et al.
have also shown that M. tuberculosis-induced apo-
ptosis of human monocytes is coupled with an increased
release of IL-1. This effect is inhibited by the neutral-
isation of the mycobacterial 19-kDa lipoprotein.69,70
However, the observation that chronic stimulation of
TLR2 by M. tuberculosis 19-kDa lipoprotein inhibits
IFN-g dependent induction of major histocompatibil-
ity complex (MHC) class II expression and Ag pre-
sentation in a mouse model, allowing M. tuberculosis
to evade detection by CD41 T-lymphocytes, provides
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a mechanism whereby mycobacteria may persist un-
disturbed in host cells.71 Similar results have also been
shown in 19-kDa stimulated human macrophages.72
In addition, the 19-kDa dependent dysregulation of the
MHC-class I processing pathway, through the inhibi-
tion of phagosome maturation and Ag degradation,
with a resulting decrease in peptide regurgitation, fur-
ther contributes to immune evasion.73
INFECTION-INDUCED APOPTOSIS AND 
CROSS-PRIMING: CONSEQUENCES FOR 
T-CELL IMMUNITY
Yrlid et al. observed that apoptosis induction by bac-
terial infection of macrophages may not be a quies-
cent death that allows pathogens to escape recognition
by the immune system, but contributes to an antimi-
crobial immune response on engulfment by by-
stander cells.74 They showed that antigens derived
from Salmonella-infected macrophages undergoing
apoptosis were presented on MHC-class II and MHC-
class I molecules by bystander dendritic cells (DCs)
after internalisation of apoptotic cells. It was previously
shown that human DCs are able to efficiently present
Ags derived from apoptotic cells and stimulate class-
I-restricted cytotoxic CD81 T lymphocytes.75 Apo-
ptotic infected cells may efficiently provide antigen for
cross-presentation in many different types of infection.
Cross-priming would be beneficial to the host because
it results in CD81 T-cell activation in those cases in
which the pathogen does not directly infect an antigen
presenting cell (APC) or when the pathogen inhibits
antigen presentation.76,77 Mycobacteria-induced apo-
ptosis of macrophages causes the release of apoptotic
vesicles that carry mycobacterial antigens to uninfected
bystander DCs. The engulfment of these vesicles, con-
taining both proteins and glycolipids, is essential for
antigen presentation, through MHC-class I and CD1b
molecules, to efficiently prime CD81 T-cells (Figure 5).78
CONCLUSIONS
Modulation of target cell apoptosis in response to in-
fection with mycobacteria and its effect on pathogen
viability are not completely understood. Mycobac-
teria possess both apoptotic and anti-apoptotic sig-
nals that suggest the existence of an inverse correla-
tion between pathogen virulence and its ability to
induce target cell apoptosis. Moreover, the host cell
features, the cytokine pattern in the culture media and
the host genetic background are additional factors
able to modulate the outcome of the infection. The
question as to whether target cell apoptosis is benefi-
cial to the host or rather to the pathogen still remains
open. As shown in Figure 6, killing of target cells may
favour mycobacteria by reducing the number of effi-
cient APCs and interfere with the induction of an ap-
propriate cell-mediated immune response. Indeed, if
there are fewer target cells serving as protected patho-
gen sanctuaries, the number of surviving bacilli will
decrease, leading to resolution of the infection. Con-
versely, prevention of host cell apoptosis may be con-
sidered as an economy strategy of the immune system to
conserve activated APC to generate an effective T-cell
memory. This mechanism may be useful to ultimately
eliminate both the infected cell and the pathogen.
However, as previously discussed, the more recent
observations suggesting that infection-induced apo-
ptosis modulates inflammation and that immune re-
sponses provide new mechanisms of host-pathogen in-
teraction should be further clarified. In conclusion,
additional efforts are required to obtain insights into
how apoptosis may influence the pathogenesis of TB.
A better understanding of apoptosis, of its related
mechanisms and of its ability to modulate the immune
response may offer new strategies to decipher the
complex cross-talk of mycobacteria with humans.
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Figure 5 Dendritic cell mediated cross-priming of effector T
CD81 cells by microbial antigens from phagocytosed mycobacteria-
infected apoptotic cells. MHC 5 major histocompatibility complex.
Figure 4 Apoptosis and inflammation: role of mycobacterial
lipoproteins. NF 5 nuclear factor.
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R É S U M É
L’apoptose est un processus de mort cellulaire pro-
grammé physiologiquement dont les troubles jouent un
rôle important dans les différentes maladies infectieuses
humaines. On sait qu’un nombre croissant d’agents
pathogènes intracellulaires induisent une apoptose des
cellules-cible alors que quelques autres parasites l’inhibent.
A l’opposé de la nécrose, l’apoptose est un événement
immunologique silencieux survenant sans inflammation.
L’apoptose induite par l’infection au niveau de cellules-
cible peut être une stratégie couronnée de succès pour éli-
miner le pathogène et assurer la survie de l’hôte. A l’inverse,
l’inhibition de l’apoptose peut représenter un mécanisme
d’adaptation assurant la survie de l’agent pathogène alors
qu’elle peut être utile à l’hôte pour l’initiation d’une ré-
ponse immune efficace.
L’augmentation mondiale de la tuberculose a stimulé
de nombreuses recherches visant à définir l’interaction
entre Mycobacterium tuberculosis et le système im-
munitaire. M. tuberculosis possède des stratégies sophis-
tiquées pour circonvenir son destin au sein des cellules
monocytaires cible. L’apoptose des macrophages alvéo-
laires et des monocytes a été décrite comme une consé-
quence de l’infection M. tuberculosis. De plus, l’observa-
tion selon laquelle les lipoprotéines mycobactériennes
activent les macrophages à travers un récepteur «toll-
like» (TLR) 2 suggère que les récepteurs de la réponse
innée contribuent à la défense contre M. tuberculosis. Il
est prouvé que l’apoptose induite par TLR module l’in-
flammation et l’activation immunitaire au cours de l’in-
fection M. tuberculosis. Finalement, le rôle des cellules
infectées en apoptose comme source d’antigènes micro-
biens pour l’amorçage croisé des cellules T effectrices est
également mentionné.
R E S U M E N
La apoptosis es un mecanismo fisiológico de muerte ce-
lular programada, cuya disfunción juega un papel pri-
mordial en diferentes enfermedades infecciosas en el
hombre. Cada vez se conocen más patógenos intracelu-
lares que inducen la apoptosis de sus células diana y otros
que la inhiben. A diferencia de la necrosis, la apoptosis
es un evento inmunológico silencioso que ocurre sin in-
flamación. La apoptosis de la célula diana, inducida por
la infección, puede corresponder a una estrategia exitosa
para eliminar el patógeno y garantizar la supervivencia
del huésped. Por el contrario, la inhibición de la apoptosis
podría representar un mecanismo de adaptación para la
supervivencia del patógeno, y al mismo tiempo favorecer
al huésped facilitando el comienzo de una respuesta in-
munitaria eficaz.
El incremento mundial de la tuberculosis ha estimu-
lado la investigación que busca definir la interacción en-
tre Mycobacterium tuberculosis y el sistema inmunita-
rio. M. tuberculosis dispone de estrategias sofisticadas
para evitar su destino dentro de las células diana mono-
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cíticas. Se ha descrito la apoptosis de macrófagos alveo-
lares y de monocitos como consecuencia de la infección
por M. tuberculosis. Además, la observación de que las
lipoproteínas micobacterianas activan los macrófagos a
través del receptor Toll en drosófila (TLR-2) indica la
existencia de inmunorreceptores innatos que contribuyen
a la defensa contra M. tuberculosis. Existen indicios de
que la apoptosis inducida por el TLR-2 regula la infla-
mación y la activación inmunitaria durante la infección
por M. tuberculosis. Por último, también se discute el
papel de las células apoptóticas infectadas, como fuente
de antígenos micobacterianos para la sensibilización
cruzada de las células T efectoras.
